Home GPN Vaccines

GPN Vaccines

In operation
Undisclosed
Pneumococcal Vaccine Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

GPN Vaccines is a biotechnology company developing a vaccine against Streptococcus pneumoniae, which causes life-threatening pneumonia, bacteremia, meningitis, and otitis media. Every year, it causes 1-2 million deaths globally and results in more child deaths than AIDS, malaria, and tuberculosis combined. There are now over 100 different serotypes of Streptococcus pneumoniae, and the best vaccines currently on the market can only protect against 20 of them. GPN Vaccines' product, called Gamma PN™, is being developed to protect both children and adults from all strains of Streptococcus pneumoniae, regardless of serotype.
GPN Vaccines, Ltd.
Adelaide,SouthAustralia,Australia
unclear
January 01, 2017
--

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Concept
Respiratory Diseases
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)